Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of ILK polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ce |
More info about ILK polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB3355 |
| Product name: | ILK polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of ILK. |
| Gene id: | 3611 |
| Gene name: | ILK |
| Gene alias: | DKFZp686F1765|P59 |
| Gene description: | integrin-linked kinase |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to residues surrounding S343 of human ILK. |
| Protein accession: | Q13418;NP_004508 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of MDA-MB-435 cell lysate (35 ug/lane) with ILK polyclonal antibody (Cat # PAB3355). |
| Applications: | WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.Troussard AA, Mawji NM, Ong C, Mui A, St -Arnaud R, Dedhar S. J Biol Chem. 2003 Jun 20;278(25):22374-8. Epub 2003 Apr 8. |